SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/05/23 Ionis Pharmaceuticals Inc. 8-K:5,9 6/01/23 10:171K Broadridge Fin’l So… Inc |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 42K 5: R1 Document and Entity Information HTML 45K 8: XML IDEA XML File -- Filing Summary XML 11K 6: XML XBRL Instance -- brhc20054000_8k_htm XML 15K 7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 3: EX-101.LAB XBRL Labels -- ions-20230601_lab XML 63K 4: EX-101.PRE XBRL Presentations -- ions-20230601_pre XML 45K 2: EX-101.SCH XBRL Schema -- ions-20230601 XSD 14K 9: JSON XBRL Instance as JSON Data -- MetaLinks 13± 20K 10: ZIP XBRL Zipped Folder -- 0001140361-23-028261-xbrl Zip 15K
i 33-0336973
|
||
(Commission File No.)
|
(IRS Employer Identification No.)
|
i ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
i ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
i Common Stock, $.001 Par Value
|
“ i IONS”
|
i The Nasdaq Stock Market, LLC
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
FOR
|
WITHHELD
|
BROKER NON-VOTES
|
|
Spencer R. Berthelsen
|
91,194,334
|
28,917,691
|
9,823,268
|
Joan E. Herman
|
115,174,011
|
4,938,014
|
9,823,268 |
B. Lynne Parshall
|
101,641,511
|
18,470,514
|
9,823,268 |
Joseph H. Wender
|
88,160,292
|
31,951,733
|
9,823,268 |
FOR
|
AGAINST
|
ABSTAIN
|
BROKER NON-VOTES
|
117,265,241
|
2,746,636
|
100,148
|
9,823,268
|
1 YEAR
|
2 YEARS
|
3 YEARS
|
ABSTAIN
|
119,423,064
|
134,181
|
475,080
|
79,700
|
FOR
|
AGAINST
|
ABSTAIN
|
BROKER NON-VOTES
|
88,929,162
|
31,115,758
|
67,105
|
9,823,268
|
FOR
|
AGAINST
|
ABSTAIN
|
BROKER NON-VOTES
|
100,409,115
|
19,628,971
|
73,939
|
9,823,268
|
FOR
|
AGAINST
|
ABSTAIN
|
BROKER NON-VOTES
|
127,567,008
|
2,276,019
|
92,266
|
0
|
Item 9.01. |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Ionis Pharmaceuticals, Inc.
|
||
Dated: June 5, 2023
|
By:
|
|
Executive Vice President, Chief Legal Officer and General Counsel
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/5/23 | |||
For Period end: | 6/1/23 | |||
4/20/23 | ARS, DEF 14A, DEFA14A | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/24/23 Ionis Pharmaceuticals Inc. S-3ASR 11/24/23 4:299K Broadridge Fin’l So… Inc 8/11/23 Ionis Pharmaceuticals Inc. S-8 8/11/23 4:73K Broadridge Fin’l So… Inc |